We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$32.2B
AUM Growth
+$1.15B
Cap. Flow
+$886M
Cap. Flow %
2.75%
Top 10 Hldgs %
14.34%
Holding
3,060
New
26
Increased
2,469
Reduced
354
Closed
63

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$23.3M
2
XOM icon
ExxonMobil
XOM
+$22.8M
3
AAPL icon
Apple
AAPL
+$21.5M
4
WFC icon
Wells Fargo
WFC
+$19.8M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 14.4%
2 Financials 14.39%
3 Healthcare 13.67%
4 Industrials 10.84%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVC
1976
DELISTED
Invacare Corporation
IVC
$747K ﹤0.01%
56,739
+4,665
+9% +$66.2K
ANAT
1977
DELISTED
American National Group, Inc. Common Stock
ANAT
$745K ﹤0.01%
6,452
+60
+0.9% +$6.14K
MRD
1978
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
$743K ﹤0.01%
72,986
-550
-0.7% -$6.51K
GABC icon
1979
German American Bancorp
GABC
$1.92B
$740K ﹤0.01%
34,458
+6,030
+21% +$127K
MUFG icon
1980
Mitsubishi UFJ Financial
MUFG
$253B
$738K ﹤0.01%
160,826
ICON
1981
DELISTED
Iconix Brand Group, Inc.
ICON
$736K ﹤0.01%
9,142
+833
+10% +$60.3K
NTRI
1982
DELISTED
NutriSystem, Inc.
NTRI
$734K ﹤0.01%
35,187
+190
+0.5% +$3.76K
IDT icon
1983
IDT Corp
IDT
$1.64B
$733K ﹤0.01%
66,569
+7,852
+13% +$71K
USPH icon
1984
US Physical Therapy
USPH
$1.18B
$733K ﹤0.01%
14,745
+340
+2% +$16.9K
ZOES
1985
DELISTED
Zoe's Kitchen, Inc.
ZOES
$731K ﹤0.01%
18,747
+415
+2% +$13.1K
GSIG
1986
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
$731K ﹤0.01%
51,655
+5,345
+12% +$68.6K
QLYS icon
1987
Qualys
QLYS
$6.45B
$728K ﹤0.01%
28,761
+4,840
+20% +$126K
ITCI
1988
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$728K ﹤0.01%
26,183
+680
+3% +$22.7K
DEO icon
1989
Diageo
DEO
$49.2B
$727K ﹤0.01%
6,744
SAN icon
1990
Banco Santander
SAN
$209B
$724K ﹤0.01%
173,336
PIR
1991
DELISTED
Pier 1 Imports, Inc.
PIR
$724K ﹤0.01%
5,167
-37
-0.7% -$3.77K
SPPI
1992
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$717K ﹤0.01%
112,685
+7,930
+8% +$40.7K
VASC
1993
DELISTED
Vascular Solutions Inc
VASC
$717K ﹤0.01%
22,041
+1,375
+7% +$39.6K
STAY
1994
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$715K ﹤0.01%
43,879
-2,360
-5% -$32.9K
MTUS icon
1995
Metallus
MTUS
$900M
$712K ﹤0.01%
78,243
+6,100
+8% +$44.6K
MNTA
1996
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$710K ﹤0.01%
76,808
+1,170
+2% +$12.6K
TTMI icon
1997
TTM Technologies
TTMI
$13.6B
$709K ﹤0.01%
106,640
+9,290
+10% +$57.3K
FTK icon
1998
Flotek Industries
FTK
$1.3B
$708K ﹤0.01%
16,090
+1,367
+9% +$60K
PLOW icon
1999
Douglas Dynamics
PLOW
$1.06B
$707K ﹤0.01%
30,872
+2,615
+9% +$52.6K
DVAX
2000
DELISTED
Dynavax Technologies
DVAX
$706K ﹤0.01%
36,683
+650
+2% +$13.1K

Similar funds

RhumbLine Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, RhumbLine Advisers held 3,060 positions worth $32.2B, up 3.7% from $31.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 2.9%. RhumbLine Advisers opened 26 new positions and exited 63, leaving the 3,060-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2016 buy was Willis Towers Watson: 89,353 shares worth $10.6M.
  • RhumbLine Advisers added most to Broadcom in Q1 2016, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q1 2016 reduction was Chubb, cutting an estimated $13.7M.
  • RhumbLine Advisers fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $32.2B portfolio in Q1 2016.
  • RhumbLine Advisers opened 26 new positions and closed 63 in Q1 2016.
  • RhumbLine Advisers's portfolio value rose 3.7% quarter-over-quarter to $32.2B.

Based on RhumbLine Advisers's 13F filing for Q1 2016, filed 2 May 2016.